AIM: To evaluate the clinical outcomes of the @entity1 treated for borderline @entity43 (BOT). MATERIALS AND METHODS: In this retrospective study, records of the @entity1 between November 2001 and December 2012 who underwent surgery and whose final pathological diagnosis were BOT were retrieved. RESULTS: During the study period, 78 @entity1 were diagnosed as BOT. The patho- logical diagnoses of the @entity5 were serous in 26 (33.3%) and mucinous in 52 @entity1 (66.6 %), respectively. Accuracy of frozen section diagnosis was observed in 63 of 89 @entity1 (70.7%). Sixty-eight @entity1 (87.1%) underwent complete staging procedure. According to final pathological diagnoses, Stage IA, IB, and @entity2337 were found in 52 (67%), five (6.5%), and seven (9%) @entity1 , respectively. FIGO Stages IIC and IIIC were found in one case in each (1.25%). Remaining 12 @entity1 were classified as unstaged (15%). The median follow-up time was 63 months. The authors observed only one recurrence (1.3%) and that @entity1 died of disease. CONCLUSION: The survival rate in @entity1 with BOTs confined to the ovary is excellent. Surgical staging procedure can be omitted in the @entity1 with grossly apparent Stage I mucinous @entity5 .

XXXX : a single center experience.

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient'] @entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian tumor'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumors'] @entity2337 :: ('MESH:C537984', 'Disease') :: ['IC']
@entity43 :: (MESH:D010051,Disease) :: ['Borderline epithelial ovarian tumors']
